Evaluation of the Therapeutic Efficacy of Alcoholic Extract of Tannins (Before and After Acidosis) on Laboratory Mice Experimentally Infected with the Parasite Cryptosporidium parvum

Luma Abdullatef S.N.; Firas M.B. Al-Khashab

doi:10.55544/jrasb.1.3.19

Authors

Luma Abdullatef S.N. Department of Biology, Collage of Education for Girls, University of Mosul, IRAQ.
Firas M.B. Al-Khashab Department of Biology, Collage of Education for Girls, University of Mosul, IRAQ.

DOI:

https://doi.org/10.55544/jrasb.1.3.19

Keywords:

Cryptosporidium parvum, Cypresuss semperverins, Alcoholic Extract, Acidosis, Metronidazole

Abstract

Plants extracts are the one of the most important sources that have been used in both ancient and recent to many facture variants, types of medical drugs and that was the aim of the current study to find safe, effective and available natural alternatives by measuring the therapeutic effect of the alcoholic extract of tannins before and after the acid hydrolysis of the extract, in laboratory mice experimentally infected with C. parvum and using three therapeutic concentrations (2, 1.3, 1) mg / ml, and the alcoholic extract before the acid hydrolysis proved its therapeutic efficacy with a noticeable decrease in the number of Oocyst excreted with the feces, as the Oocyst were no longer excreted from the ninth day of the treatment. Parasite Oocyst on the fifth day of treatment were treated by oral administration of the extract in infected mice, in the other hand the current study recorded that Cryptosporidiais as a common disease in the study area, with infection rate of 26%.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

M. F. Wiser, ‘and Protozoan of Humans: A Primer’, Nutr. Infect. Dis., no. January, pp. 165–187, 2021, doi: 10.1007/978-3-030-56913-6_6.

O. Article et al., Intestinal Parasitic Infections among the Pediatric Patients in a Metropolitan City of Bangladesh with Emphasis on Cryptosporidiosis, no. March. 2022.

R. Xu et al., ‘Characterization of INS-15, a metalloprotease potentially involved in the invasion of Cryptosporidium parvum’, Microorganisms, vol. 7, no. 10, 2019, doi: 10.3390/microorganisms7100452.

F. Yu et al., ‘CRISPR/Cas12a-based on-site diagnostics of Cryptosporidium parvum IId-subtype-family from human and cattle fecal samples’, Parasites and Vectors, vol. 14, no. 1, pp. 1–10, 2021, doi: 10.1186/s13071-021-04709-2.

F. S. Cunha, J. M. Peralta, and R. H. S. Peralta, ‘New insights into the detection and molecular characterization of Cryptosporidium with emphasis in Brazilian studies: A review’, Rev. Inst. Med. Trop. Sao Paulo, vol. 61, no. April, pp. 1–12, 2019, doi: 10.1590/s1678-9946201961028.

G. Certad, ‘Food and Waterborne Parasitology Is Cryptosporidium a hijacker able to drive cancer cell proliferation ?’, Food Waterborne Parasitol., vol. 27, no. April, p. e00153, 2022, doi: 10.1016/j.fawpar.2022.e00153.

R. A. Guy, C. A. Yanta, P. K. Muchaal, M. A. Rankin, and K. Thivierge, ‘Molecular characterization of Cryptosporidium isolates from humans in Ontario , Canada’, vol. 1, pp. 1–16, 2021.

A. G. Tamomh et al., ‘Prevalence of cryptosporidiosis among children with diarrhoea under five years admitted to Kosti teaching hospital, Kosti City, Sudan’, BMC Infect. Dis., vol. 21, no. 1, pp. 1–6, 2021, doi: 10.1186/s12879-021-06047-1.

A. Kumar et al., ‘Cryptosporidium parvum disrupts intestinal epithelial barrier function via altering expression of key tight junction and adherens junction proteins’, Cell. Microbiol., vol. 20, no. 6, pp. 1–13, 2018, doi: 10.1111/cmi.12830.

O. Ulusan Bagci and A. Caner, ‘The interaction of gut microbiota with parasitic protozoa’, J. Parasit. Dis., vol. 46, no. 1, pp. 8–11, 2022, doi: 10.1007/s12639-021-01443-5.

A. Dominguez-Uscanga, D. F. Aycart, K. Li, W. H. Witola, and J. E. Andrade Laborde, ‘Anti-protozoal activity of Thymol and a Thymol ester against Cryptosporidium parvum in cell culture’, Int. J. Parasitol. Drugs Drug Resist., vol. 15, no. February, pp. 126–133, 2021, doi: 10.1016/j.ijpddr.2021.02.003.

E. A. Innes, R. M. Chalmers, B. Wells, and M. C. Pawlowic, ‘A One Health Approach to Tackle Cryptosporidiosis’, Trends Parasitol., vol. 36, no. 3, pp. 290–303, 2020, doi: 10.1016/j.pt.2019.12.016.

E. Tomczak, A. N. McDougal, and A. Clinton White, ‘Resolution of Cryptosporidiosis in Transplant Recipients: Review of the Literature and Presentation of a Renal Transplant Patient Treated with Nitazoxanide, Azithromycin, and Rifaximin’, Open Forum Infect. Dis., vol. 9, no. 1, pp. 1–5, 2022, doi: 10.1093/ofid/ofab610.

F. Murakoshi et al., ‘Nullscript inhibits Cryptosporidium and Toxoplasma growth’, Int. J. Parasitol. Drugs Drug Resist., vol. 14, no. October, pp. 159–166, 2020, doi: 10.1016/j.ijpddr.2020.10.004.

A. Layal, R. Hassan, K. Ahmad, and B. S. Hamid, ‘Chemical composition and biological potentials of Lebanese Cupressus sempervirens L. leaves extracts’, J. Med. Plants Res., vol. 14, no. 6, pp. 292–299, 2020, doi: 10.5897/jmpr2019.6843.

A. E. Al-Snafi, ‘Medical importance of Cupressus sempervirens - A review’, IOSR J. Pharm., vol. 6, no. 2, pp. 66–76, 2016, [Online]. Available: www.iosrphr.org.

L. Sherin, S. Shujaat, A. Sohail, and F. Arif, ‘Synthesis and biological evaluation of novel gallic acid analogues as potential antimicrobial and antioxidant agents’, Croat. Chem. Acta, vol. 91, no. 4, pp. 551–565, 2018, doi: 10.5562/cca3429.

B. G. Patgar, S. Satish, and A. R. Shabaraya, ‘Essential Oil of Cupressus Sempervirens: A Brief Review’, World J. Pharm. Pharm. Sci., vol. 10, no. 4, pp. 864–872, 2021, doi: 10.20959/wjpps20214-18713.

V. A. Amorós, ‘The history of conifers in Egypt, part I’:, News from past Prog. African archaeobotany, pp. 3–12, 2018, doi: 10.2307/j.ctt20p56fr.5.

C. Pericleous and N.-G. Eliades, ‘An approach for the mass propagation of Cupressus sempervirens L. (Cupressaceae), for quality propagule production’, Res. Ideas Outcomes, vol. 6, 2020, doi: 10.3897/rio.6.e52947.

I. E. Orhan and I. Tumen, ‘Potential of Cupressus sempervirens (Mediterranean Cypress) in Health’, Mediterr. Diet An Evidence-Based Approach, no. January, pp. 639–647, 2015, doi: 10.1016/B978-0-12-407849-9.00057-9.

M. Khudhair and N. Al-Niaeemi, ‘Experimental study of heat-killed oocysts of Cryptosporidium Parvum in Balb/ c Mice’, J. Educ. Sci., vol. 29, no. 2, pp. 158–173, 2020, doi: 10.33899/edusj.2020.165305.

J. B. Harborne, ‘Methods of Plant Analysis’, Phytochem. Methods, pp. 1–32, 1984, doi: 10.1007/978-94-009-5921-7_1.

S. Abada, ‘Effect of garlic and pomegranate extract on rats experimentally infected with Cryptosporidium parvum and its comparison with metronidazole’, 2015.

M. Al-Khalil, ‘An epidemiological and molecular study to diagnose Cryptosporidium ssp in some areas of Dohuk Governorate’, 2017.

S. Al-Sultan, ‘Diagnostic, epidemiological and pathological study of Cryptosporidium parvum In children under five years of age in some areas of Nineveh Governorate’, 2021.

P. Alvarez-Pellitero et al., ‘Cryptosporidium scophthalmi n. sp. (Apicomplexa: Cryptosporidiidae) from cultured turbot Scophthalmus maximus. Light and electron microscope description and histopathological study’, Dis. Aquat. Organ., vol. 62, no. 1–2, pp. 133–145, 2004, doi: 10.3354/dao062133.

M. Behbahani, M. Shanehsazzadeh, and M. J. Hessami, ‘Optimization of callus and cell suspension cultures of Barringtonia racemosa (Lecythidaceae family) for lycopene production’, Sci. Agric., vol. 68, no. 1, pp. 69–76, 2011, doi: 10.1590/s0103-90162011000100011.